The situation regarding valsartan containing products that may be effected has been issued by the Medicines Authority Malta
The release is available on http://www.medicinesauthority.gov.mt/news-details?id=FF9F and is being reproduced below
As you know, over the past 48 hours there has been an evolving situation with regards to a number of valsartan containing products.
The following is a list of resources which we feel are useful when guiding patients.
Randomised controlled trial demonstrates significant effect on adherence rates and serum urate levels over 12 weeks
In a survey to assess treatment preferences for high blood pressure, respondents were more likely to choose a daily cup of tea or a pill over exercise, according to preliminary research presented at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions 2018, a premier global exchange of the latest advances in quality of care and outcomes research in cardiovascular disease and stroke for researchers, healthcare professionals and policymakers.
Long-term proton pump inhibitor (PPI) use does not increase the risk of hip fracture among persons with Alzheimer’s disease, according to a new study from the University of Eastern Finland. The risk of hip fracture was slightly increased for PPI use of less than one year, but not for long-term or cumulative use during a follow-up period of 10 years. In addition, there were no significant differences between PPI drug substances and the associated risk of hip fracture. The findings were published in Alimentary Pharmacology & Therapeutics.
The combined rate of death from any cause, heart attack or stroke within 18 months was not significantly different in patients with acute coronary syndrome (ACS) who were randomly assigned to receive dual antiplatelet therapy (DAPT) for either six months or at least 12 months after receiving a drug-eluting stent. Patients who were given DAPT for only six months, however, had more than double the risk of a heart attack compared with those treated for at least 12 months, according to research presented at the American College of Cardiology’s 67th Annual Scientific Session.